Northern Trust’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Northern Trust’s Portfolio AST.WS Stock Details AST.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-17,548	Closed	-$9K	–	4342
2017 Q2	$9K	Hold	17,548	–	–	﹤0.01%	4227
2017 Q1	$7K	Sell	17,548 -4	-0%	-$1	﹤0.01%	4209
2016 Q4	$10K	Buy	17,552 +4	+0%	+$2	﹤0.01%	4134
2016 Q3	$10K	Hold	17,548	–	–	﹤0.01%	4137
2016 Q2	$3K	Buy	+17,548	New	+$9.14K	﹤0.01%	4207

Northern Trust's AST.WS Position: Q3 2017 in Review

Northern Trust sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 17,548 shares — an estimated $9K sold.

Northern Trust first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $10K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

Northern Trust reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
Northern Trust sold 17,548 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $9K.
Northern Trust first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
Northern Trust's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $10K in Q4 2016.
3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.